Tag Archives: Atomwise

February 22, 2022
In The News
Read Article
January 26, 2022
FeaturedIn The News
Read Article
January 25, 2022
FeaturedPress Release

CSO, CFO, and GC added as technology-enabled pharma company bolsters growing management team and SAB SAN FRANCISCO, Calif. — January 25, 2022 — Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today the appointment of David Thomson, Ph.D. as Chief Scientific Officer. Additional management team appointments include Jonathan Barr […]

Read Article
August 13, 2020
Press Release

Atomwise recognized for achievements in AI-driven drug discovery and creation of the AtomNet® platform, which has tackled — and succeeded in — finding small molecule hits for more undruggable targets than any other platform NEW YORK, August 13, 2020 — CB Insights today named Atomwise to its second annual Digital Health 150 ranking, which showcases […]

Read Article
September 27, 2019
In The News

Angus Liu of FierceBiotech reports on new research on Miro1 and implications for Parkinson’s disease.

Read Article
September 26, 2019
In The News

Science Daily reports on a recent publication by researchers at Stanford, Mayo Clinic, and Atomwise.

Read Article